BRAF and colorectal carcinoma: Downstream activation of phosphatidylinositol 3-kinase and MAPK/ERK pathways by SPINK1 was noted in CRC cell lines harboring KRAS, NRAS or BRAF mutations by Tiwari et al. [33].